Congenital Hearing Loss

And the award goes to ... Norvell’s Hearing Aid Center of Zanesville and Cambridge is the inaugural recipient of the Homer and Jenny Norvell Achievement Award presented by GN ReSound. The award is given to the No. 1 ranked practice with two or fewer offices taking into consideration every facet of a practice from annual sales to customer service. "It shows our commitment to quality customer care and a devotion to caring for our customers," said Brad Norvell, owner and operator of Norvell’s Hearing Aid Center. "We are the oldest continuous, family run practice with 53 years of service to our clients." "And, it is a much deserved award," added Shirley Casterline, a long-time customer of the Cambridge location. And, the awards don’t start or stop with the latest achievement. In past years, Norvell’s has received the the Director’s Award and the Platinum Award of Better Service from the Starkey Hearing Foundation, and the M.T. Hemisthel Award. The Homer

Humans only have five senses and all of them are necessary for keeping us safe. Our vision lets us see the danger that is approaching us. Our sense of smell lets us recognize there is a toxin in the air. Our sense of touch notifies us when an object could damage our bodies. Our sense of taste lets us know when food could make us ill. And, our sense of hearing lets us know when danger is approaching and it is out of our range of sight. Unfortunately, too many people do not recognize hearing as a tool for safety. Instead, they go about their days not being able to hear when potential danger is nearby. If you have hearing loss, you should invest in hearing aids for safety. Along with recognizing when harm is approaching, hearing aids offer protection against other situations that could be potentially dangerous. If you are struggling to hear, you could have safety issues regarding: 1. Stress When you cannot hear, you lose connection with what is happening around you. This can be highl

Lavay Moore, PCC, holds a set of Sonic Captivate 60 Minirite hearing aids Monday, Feb. 17, 2020.  Billy Hefton | Enid News & Eagle ENID, Okla. — Hearing aid technology is going through an ever-changing process, with advances happening as often as two or three times a year, according to local specialists. “Hearing aids are far from where they were 10 years ago,” said Greg Kuykendall of Kuykendall Hearing Aid Center & Diagnostic Audiology. “I’ve been in this business for 35 years, and some of it I have to sit down and focus. It’s not the way we were brought up. To my 30-year son (Kyle), it’s right down his alley. It’s a pretty exciting time to be in the market now.” “Hearing aid technology is going to be continually and constantly changing,” said Jenni Grittman, hearing instrument specialist from the Hearing Group. “We’re doing a lot of fine tuning on hearing aids. If something doesn’t sound right, we can make adjustments. We’re going to see in the ne

The global IIC Hearing Aid market study covers the projection size of the market both in terms of value (Mn/Bn US$) and volume (x units). The report estimates the lookup of different local distributors in the overall market and provides the market size of the IIC Hearing Aid market using both bottom-up and top-down approaches. To investigate the key players and their market contribution, primary and secondary research has been comprehensively performed. In addition, all the figures, subdivisions, and shares have been collected with the help of trustworthy sources. In the IIC Hearing Aid market research study, 2018 is considered as the base year, and 2019-2029 is considered as the forecast period to predict the market size. The report identifies each IIC Hearing Aid market player on the basis of market share, production portfolio, and growth rate. In addition, the research study analyzes the strengths, weaknesses, opportunities and threats of the players. Make An Enquiry About This

Please enable Javascript to watch this video OKLAHOMA CITY (KFOR) - It's something that almost seems too good to be true - a pill that could help restore hearing. However, it's getting closer to becoming a reality after years of trials stemming from experts right here in Oklahoma City. This could bring hope for the estimated 58,000 Oklahomans and 466 million people worldwide dealing with noise-induced hearing loss. Currently, there's no drug treatment or cure for noise-induced hearing loss. But at the Hough Ear Institute, they've been working to make it a reality in the form of a pill. "We also have a hearing loss injection and an inner-ear drug delivery system," said Justin De Moss, with the Hough Ear Institute. For years, researchers at the Hough Ear Institute and the Oklahoma Medical Research Foundation have been working to find a pharmacological approach to improve hearing, without devices like hearing aids. The pill they've developed regene

Get inside Wall Street with StreetInsider Premium . Claim your 1-week free trial here. TRUSSVILLE, Ala. – In an effort to promote their award-winning hearing technology, hearing aid specialist in Trussville, Beltone USA, has recently offered residents in their community, who live with hearing loss, the opportunity to participate in an exclusive trial of their newest hearing aid, the Beltone Amaze™. Those who qualify for the trial were fit with the new Beltone Amaze™ hearing aid. The company hopes to receive firsthand feedback on the device’s sound quality, comfort, and appearance from participants of the trial. The high-tech hearing aid in Trussville, AL has the latest and fastest micro-processing technology built-in directly to allow simplified connectivity to most mobile devices and Beltone’s Direct Line wireless accessories. Qualified patients are offered the opportunity to try the technology with no obligation to buy but offers an exclusive rebate for those participants who wis

Share this Article You are free to share this article under the Attribution 4.0 International license. Using a hearing aid may delay cognitive decline, new research shows. Here, Julia Sarant, an associate professor in the audiology and speech pathology department in the Faculty of Medicine, Dentistry, and Health Sciences at the University of Melbourne, explains the research and how it could help people: Hearing loss is very common in older adults. You probably know someone who suffers. On average, based on studies in Australia, Europe, and the US, it affects around 32% of people aged 55 years old, and more than 70% of people aged over 70 years. But you may not know that hearing loss is independently associated with the rate of cognitive decline in older adults. Research shows us that the rate of cognitive decline increases with the severity of hearing loss. Even for people with mild hearing loss, the rate of cognitive decline can be 30 to 40% faster than for a perso

Hearing aids come in various sizes to fit the needs and desires of each user. Michael Johnson/Generations The last 15 years have seen dramatic changes in hearing devices. In many cases now, they’re invisible, long-lasting and make for much-improved quality of life. Brian Hillesland, of Wadena, is the owner and hearing aid specialist of several hearing aid centers in the region, including Jefferson Hearing Aid Center. He started using hearing aids himself about a year and a half ago, he said — as soon as he identified a steady ringing in his ears as tinnitus. He finds that using hearing aids helps mask that annoyance. But cost is a major factor in keeping many people from getting hearing aids. Hillesland said quality hearing aids can range from $2,000 to $8,000, depending on what you want them to do for you. That cost usually includes a hearing test, consultation, initial fitting, follow-up adjustments, routine cleanings, batteries and a warranty, when purchased from a hearing aid

Results from three clinical trials expected in 2020 including the Phase 3 trial of OTIVIDEX™  in Ménière’s disease Current capital funds operations into 2021 Conference call and webcast today at 4:30 p.m. ET SAN DIEGO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today reported financial results for the fourth quarter and year ended December 31, 2019 and provided an update on its product pipeline and corporate activities. The company will host a conference call and webcast today at 4:30 p.m. ET to discuss recent highlights and financial results. “We have positioned Otonomy for a transformational year in 2020 with three clinical trial readouts including the Phase 3 trial of OTIVIDEX in Ménière’s disease, Phase 2 trial of OTO-313 in tinnitus, and Phase 1/2 trial of OTO-413 in hearing loss,” said David A. Weber, Ph.D., president and CEO of Otonomy. “In addition to these cl